Loading...
PetVivo Holdings, Inc.
PETVW•NASDAQ
Healthcare
Medical - Devices
$0.04
$0.00(0.00%)
PetVivo Holdings, Inc. (PETVW) Financial Performance & Income Statement Overview
Review PetVivo Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.62%
↑ 5.62%
Operating Income Growth
-21.62%
↓ 21.62%
Net Income Growth
-25.90%
↓ 25.90%
Operating Cash Flow Growth
-9.20%
↓ 9.20%
Operating Margin
-902.22%
↓ 902.22%
Gross Margin
108.52%
↑ 108.52%
Net Profit Margin
-902.70%
↓ 902.70%
ROE
-2806.96%
↓ 2806.96%
ROIC
-4900.23%
↓ 4900.23%
PetVivo Holdings, Inc. (PETVW) Income Statement & Financial Overview
Review PetVivo Holdings, Inc.'s (PETVW) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $583313.00 | $200720.00 | $123751.00 | $48266.00 |
| Cost of Revenue | $61497.00 | $21162.00 | $12994.00 | -$177090.00 |
| Gross Profit | $521816.00 | $179558.00 | $110757.00 | $225356.00 |
| Gross Profit Ratio | $0.89 | $0.89 | $0.89 | $4.67 |
| R&D Expenses | $371953.00 | $465174.00 | $387515.00 | $572858.00 |
| SG&A Expenses | $1.91M | $1.89M | $1.77M | $2.30M |
| Operating Expenses | $2.28M | $2.35M | $2.16M | $2.88M |
| Total Costs & Expenses | $2.34M | $2.37M | $2.17M | $2.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $24378.00 | $0.00 | $2631.00 | $0.00 |
| Depreciation & Amortization | $32074.00 | $0.00 | $33497.00 | $33159.00 |
| EBITDA | -$1.70M | -$2.17M | -$2.01M | -$3.15M |
| EBITDA Ratio | -$2.92 | -$10.83 | -$16.25 | -$47.41 |
| Operating Income | -$1.76M | -$2.17M | -$2.04M | -$2.65M |
| Operating Income Ratio | -$3.01 | -$10.83 | -$16.52 | -$54.90 |
| Other Income/Expenses (Net) | $1367.00 | -$2453.00 | -$2631.00 | -$921.00 |
| Income Before Tax | -$1.76M | -$2.18M | -$2.05M | -$2.65M |
| Income Before Tax Ratio | -$3.01 | -$10.84 | -$16.54 | -$54.92 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $330413.00 |
| Net Income | -$1.76M | -$2.18M | -$2.05M | -$2.65M |
| Net Income Ratio | -$3.01 | -$10.84 | -$16.54 | -$54.92 |
| EPS | -$0.09 | -$0.11 | -$0.11 | -$0.19 |
| Diluted EPS | -$0.09 | -$0.11 | -$0.11 | -$0.19 |
| Weighted Avg Shares Outstanding | $20.63M | $20.10M | $18.68M | $13.97M |
| Weighted Avg Shares Outstanding (Diluted) | $20.63M | $20.10M | $18.68M | $13.97M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan